6VC0 image
Deposition Date 2019-12-19
Release Date 2020-07-08
Last Version Date 2023-10-11
Entry Detail
PDB ID:
6VC0
Keywords:
Title:
Crystal structure of the horse MLKL pseudokinase domain
Biological Source:
Source Organism:
Equus caballus (Taxon ID: 9796)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.75 Å
R-Value Free:
0.23
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Mixed lineage kinase domain like pseudokinase
Gene (Uniprot):MLKL
Chain IDs:A, B, C
Chain Length:292
Number of Molecules:3
Biological Source:Equus caballus
Primary Citation
Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues.
Nat Commun 11 3060 3060 (2020)
PMID: 32561735 DOI: 10.1038/s41467-020-16823-3

Abstact

The MLKL pseudokinase is the terminal effector in the necroptosis cell death pathway. Phosphorylation by its upstream regulator, RIPK3, triggers MLKL's conversion from a dormant cytoplasmic protein into oligomers that translocate to, and permeabilize, the plasma membrane to kill cells. The precise mechanisms underlying these processes are incompletely understood, and were proposed to differ between mouse and human cells. Here, we examine the divergence of activation mechanisms among nine vertebrate MLKL orthologues, revealing remarkable specificity of mouse and human RIPK3 for MLKL orthologues. Pig MLKL can restore necroptotic signaling in human cells; while horse and pig, but not rat, MLKL can reconstitute the mouse pathway. This selectivity can be rationalized from the distinct conformations observed in the crystal structures of horse and rat MLKL pseudokinase domains. These studies identify important differences in necroptotic signaling between species, and suggest that, more broadly, divergent regulatory mechanisms may exist among orthologous pseudoenzymes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures